Scale-up from clinical to commercial

A risk-based and GMP-compliant approach ensuring reliable industrial scalability

• Our scale-up process supports the transition from clinical development to commercial manufacturing through a controlled, science- and risk-based framework for Human and Animal Health APIs.
• Process knowledge is systematically translated into industrial performance by evaluating critical quality attributes (CQAs), critical process parameters (CPPs), and scale-dependent variables to ensure consistency, robustness, and product quality.
• Scale-up activities are fully aligned with industrial requirements, including equipment design, containment strategies, cross-contamination control, and operator safety, ensuring that development assumptions are sustainable at commercial scale.
• For our customers, this means reduced scale-up risk, predictable timelines, and confidence that clinical processes can be successfully transformed into robust and compliant commercial manufacturing.
• Seamless progression from lab (g) → kilolab (kg) → pilot → commercial (tons).